Connection

Jacqueline Kraveka to Neuroblastoma

Back to Details
This is a "connection" page, showing publications Jacqueline Kraveka has written about Neuroblastoma.
Jacqueline Kraveka
Connection Strength
3.025
Neuroblastoma
  1. A pilot study of genomic-guided induction therapy followed by immunotherapy with difluoromethylornithine maintenance for high-risk neuroblastoma. Cancer Rep (Hoboken). 2022 Nov; 5(11):e1616.
    View in: PubMed
    Score: 0.754
  2. Maintenance DFMO Increases Survival in High Risk Neuroblastoma. Sci Rep. 2018 09 27; 8(1):14445.
    View in: PubMed
    Score: 0.591
  3. Involvement of dihydroceramide desaturase in cell cycle progression in human neuroblastoma cells. J Biol Chem. 2007 Jun 08; 282(23):16718-28.
    View in: PubMed
    Score: 0.264
  4. Involvement of endogenous ceramide in the inhibition of telomerase activity and induction of morphologic differentiation in response to all-trans-retinoic acid in human neuroblastoma cells. Arch Biochem Biophys. 2003 Nov 15; 419(2):110-9.
    View in: PubMed
    Score: 0.211
  5. A Phase I Trial of TB-403 in Relapsed Medulloblastoma, Neuroblastoma, Ewing Sarcoma, and Alveolar Rhabdomyosarcoma. Clin Cancer Res. 2022 09 15; 28(18):3950-3957.
    View in: PubMed
    Score: 0.195
  6. A subset analysis of a phase II trial evaluating the use of DFMO as maintenance therapy for high-risk neuroblastoma. Int J Cancer. 2020 12 01; 147(11):3152-3159.
    View in: PubMed
    Score: 0.166
  7. Effect of Tandem Autologous Stem Cell Transplant vs Single Transplant on Event-Free Survival in Patients With High-Risk Neuroblastoma: A Randomized Clinical Trial. JAMA. 2019 08 27; 322(8):746-755.
    View in: PubMed
    Score: 0.158
  8. Updates in Diagnosis, Management, and Treatment of Neuroblastoma. Radiographics. 2018 Mar-Apr; 38(2):566-580.
    View in: PubMed
    Score: 0.142
  9. A Phase 1 Trial of TPI 287 as a Single Agent and in Combination With Temozolomide in Patients with Refractory or Recurrent Neuroblastoma or Medulloblastoma. Pediatr Blood Cancer. 2016 Jan; 63(1):39-46.
    View in: PubMed
    Score: 0.119
  10. A Phase I Trial of DFMO Targeting Polyamine Addiction in Patients with Relapsed/Refractory Neuroblastoma. PLoS One. 2015; 10(5):e0127246.
    View in: PubMed
    Score: 0.117
  11. Feasibility of implementing molecular-guided therapy for the treatment of patients with relapsed or refractory neuroblastoma. Cancer Med. 2015 Jun; 4(6):871-86.
    View in: PubMed
    Score: 0.115
  12. Neuroblastoma in an adult: case presentation and literature review. Ann Clin Lab Sci. 2013; 43(1):81-4.
    View in: PubMed
    Score: 0.099
  13. Cell density-dependent reduction of dihydroceramide desaturase activity in neuroblastoma cells. J Lipid Res. 2012 May; 53(5):918-928.
    View in: PubMed
    Score: 0.094
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.